Home
PSTV
PSTV News

Latest PLUS THERAPEUTICS Inc. (PSTV) News on January 23, 2025

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

GlobeNewswire

a month ago

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 12/10/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 12/09/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 12/06/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 12/05/2024

Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

GlobeNewswire

2 months ago

Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 12/04/2024

Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply

GlobeNewswire

2 months ago

Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 12/03/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 12/02/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/29/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/27/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/26/2024

CNSide Diagnostics reports data from trial of CNSide CSF Assay in LM diagnosis

Medical Device Network

2 months ago

CNSide Diagnostics reports data from trial of CNSide CSF Assay in LM diagnosis

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference

GlobeNewswire

2 months ago

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/25/2024

Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases

GlobeNewswire

2 months ago

Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/22/2024

Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases

GlobeNewswire

2 months ago

Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/21/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/20/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/19/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/18/2024

Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

2 months ago

Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/15/2024

Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...

GuruFocus.com

2 months ago

Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...

Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

2 months ago

Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/14/2024

ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates

Zacks

2 months ago

ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/13/2024

Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates

Zacks

2 months ago

Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/11/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/08/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 11/07/2024

MT Newswires

3 months ago

Plus Therapeutics, SpectronRx Collaborate to Manufacture Rhenium Obisbemeda Radiotherapy

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

GlobeNewswire

3 months ago

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 11/06/2024

Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024

GlobeNewswire

3 months ago

Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 11/05/2024

Zoetis (ZTS) Q3 Earnings and Revenues Beat Estimates

Zacks

3 months ago

Zoetis (ZTS) Q3 Earnings and Revenues Beat Estimates

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 11/04/2024

MT Newswires

3 months ago

Plus Therapeutics Gets Additional Time to Regain Compliance With Nasdaq Listing Requirement

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 11/01/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/31/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/30/2024

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas

GlobeNewswire

3 months ago

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/29/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/28/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/25/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/24/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/23/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/22/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/21/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/18/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/17/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/16/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/15/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/14/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/11/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/10/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/09/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/08/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/07/2024

MT Newswires

4 months ago

Plus Therapeutics Files $100 Million Mixed Shelf

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/04/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/03/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/02/2024

Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting

GlobeNewswire

4 months ago

Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/01/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/30/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/27/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/26/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/25/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/24/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/23/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/20/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/19/2024

Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting

GlobeNewswire

4 months ago

Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/18/2024

Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

5 months ago

Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Plus Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Plus Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

5 months ago

Q2 2024 Plus Therapeutics Inc Earnings Call

Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

5 months ago

Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference

GlobeNewswire

5 months ago

Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference

Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference

GlobeNewswire

5 months ago

Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference

Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024

GlobeNewswire

5 months ago

Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference

GlobeNewswire

6 months ago

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference

Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer

GlobeNewswire

7 months ago

Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

7 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

7 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

7 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

7 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

7 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

7 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

7 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

7 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

MT Newswires

8 months ago

Plus Therapeutics to Receive $3.3 Million Advance Payment From CPRIT For Radiotherapeutic Development Program

Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT

GlobeNewswire

8 months ago

Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT

Plus Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

8 months ago

Plus Therapeutics Announces New Employment Inducement Grants

GuruFocus.com

8 months ago

Plus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...

Share on Social Networks: